We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+8.36%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$6.71B
AUM Growth
+$261M
Cap. Flow
-$70.9M
Cap. Flow %
-1.06%
Top 10 Hldgs %
9.42%
Holding
1,543
New
117
Increased
248
Reduced
313
Closed
122

Top Sells

Rank Stock Value
1
CB icon
Chubb
CB
+$35.1M
2
ES icon
Eversource Energy
ES
+$35M
3
MAT icon
Mattel
MAT
+$33.4M
4
SWK icon
Stanley Black & Decker
SWK
+$29.6M
5
ADM icon
Archer Daniels Midland
ADM
+$29.2M

Sector Composition

Rank Sector Weight
1 Financials 20.78%
2 Industrials 15.06%
3 Technology 12.92%
4 Consumer Discretionary 9.48%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QUMU
1326
DELISTED
Qumu Corp.
QUMU
$195K ﹤0.01%
85,200
BRT
1327
BRT Apartments
BRT
$282M
$194K ﹤0.01%
24,200
AXR icon
1328
AMREP Corp
AXR
$120M
$193K ﹤0.01%
24,200
+7,200
+42% +$44.7K
ATLC icon
1329
Atlanticus Holdings
ATLC
$1.63B
$190K ﹤0.01%
62,112
UTSI icon
1330
UTStarcom
UTSI
$23.5M
$187K ﹤0.01%
22,550
RBPAA
1331
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
$185K ﹤0.01%
78,195
NVET
1332
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$185K ﹤0.01%
44,400
HNR
1333
DELISTED
Harvest Natural Resources
HNR
$184K ﹤0.01%
57,350
REED
1334
DELISTED
Reeds, Inc. Common Stock
REED
$181K ﹤0.01%
970
NVTR
1335
DELISTED
Nuvectra Corporation Common Stock
NVTR
$180K ﹤0.01%
+26,000
New +$179K
INTX
1336
DELISTED
Intersections, Inc.
INTX
$177K ﹤0.01%
97,800
ENG
1337
DELISTED
ENGlobal Corp
ENG
$176K ﹤0.01%
14,538
-5,000
-26% -$55.1K
ACFC
1338
DELISTED
Atlantic Coast Financial Corporation
ACFC
$176K ﹤0.01%
28,050
CAS
1339
DELISTED
A M Castle & Co
CAS
$176K ﹤0.01%
220,200
NTIC icon
1340
Northern Technologies International Corp
NTIC
$79.9M
$175K ﹤0.01%
27,900
RVP icon
1341
Retractable Technologies
RVP
$19.8M
$175K ﹤0.01%
68,200
ITP icon
1342
IT Tech Packaging
ITP
$3.04M
$172K ﹤0.01%
16,381
CASC
1343
DELISTED
Cascadian Therapeutics, Inc.
CASC
$172K ﹤0.01%
17,517
+1,534
+10% +$10.9K
PLX icon
1344
Protalix BioTherapeutics
PLX
$187M
$169K ﹤0.01%
30,259
GNCMA
1345
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$169K ﹤0.01%
+12,300
New +$175K
UFAB
1346
DELISTED
Unique Fabricating, Inc.
UFAB
$166K ﹤0.01%
+13,600
New +$177K
CBAN icon
1347
Colony Bankcorp
CBAN
$465M
$165K ﹤0.01%
16,668
ENSV
1348
DELISTED
Enservco Corp.
ENSV
$165K ﹤0.01%
19,020
-333
-2% -$3.18K
FORM icon
1349
FormFactor
FORM
$8.48B
$163K ﹤0.01%
15,000
-15,000
-50% -$151K
ESXB
1350
DELISTED
Community Bankers Trust Corporation
ESXB
$163K ﹤0.01%
30,000

Similar funds

Bridgeway Capital Management's Q3 2016 Portfolio in Review

As of Q3 2016, Bridgeway Capital Management held 1,543 positions worth $6.71B, up 4% from $6.45B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Bridgeway Capital Management's Q3 2016 filing shows 117 new, 248 increased, 313 reduced and 122 closed positions. Its largest new stake was Trane Technologies: 590,700 shares worth $40.1M. The largest sale was Chubb, an estimated $35.1M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 21% a quarter earlier, followed by Industrials and Technology.

  • Bridgeway Capital Management's largest Q3 2016 buy was Trane Technologies: 590,700 shares worth $40.1M.
  • Bridgeway Capital Management added most to Applied Materials in Q3 2016, an estimated $46.1M increase.
  • Bridgeway Capital Management's biggest Q3 2016 reduction was Foot Locker, cutting an estimated $26.2M.
  • Bridgeway Capital Management fully exited Chubb in Q3 2016, selling an estimated $35.1M.
  • Bridgeway Capital Management's ten largest holdings make up 9.4% of its $6.71B portfolio in Q3 2016.
  • Bridgeway Capital Management opened 117 new positions and closed 122 in Q3 2016.
  • Bridgeway Capital Management's portfolio value rose 4% quarter-over-quarter to $6.71B.

Based on Bridgeway Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.